Phase I and pharimacokinetic trial of a novel inhibitor of NAD biosynthesis in patients with solid tumors.

被引：0

作者：

Holen, KD

Bolling, C

Saltz, LB

Graefe, T

Ty, V

Sogo, N

Starkmann, H

Burk, KH

Hollywood, E

Hanauske, AR

机构：

[1] St Georg Hosp, Hamburg, Germany

[2] Univ Wisconsin, Madison, WI USA

[3] MSKCC, New York, NY USA

[4] Fujisawa Pharmaceut Co Ltd, Osaka, Japan

[5] Fujisawa Deutschland GmbH, Munich, Germany

[6] ClinDesci GmbH, Munich, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6158S / 6158S

页数：1